Benefits and Effectiveness of Using Paullinia cupana: A Review Article

Adele Salomão-Oliveira^1, , Emerson Silva Lima², Helyde Albuquerque Marinho³ and Rosany Piccolotto Carvalho⁴

¹Multi-Institutional Post-Graduate Biotechnology Program, Universidade Federal do Amazonas (UFAM), Manaus, AM, Brazil

²Pharmaceutical Sciences Departement, Universidade Federal do Amazonas (UFAM), Manaus, AM, Brazil

³Department of Research, Society and Health, Instituto Nacional de Pesquisas da Amazônia (INPA), Manaus-AM, Brazil

⁴Physiological Science Departament, Universidade Federal do Amazonas (UFAM), Manaus, AM, Brazil

Cite this paper:
Adele Salomão-Oliveira, Emerson Silva Lima, Helyde Albuquerque Marinho and Rosany Piccolotto Carvalho. Benefits and Effectiveness of Using Paullinia cupana: A Review Article. Journal of Food and Nutrition Research. 2018; 6(8):497-503. doi: 10.12691/jfnr-6-8-2

Abstract

Guarana is native to the Amazonian region of Brazil and, widely used in liquid preparations due to its stimulating effect, along with other therapeutic properties. Its chemical components, methylxanthines and condensed tannins, exhibiting a marked biological activity, may be found in commercially available powdered guarana brands at varying levels, possibly due to their provenance and drying processes. However, the chemical standardization of its extract maintains the same quantified content of active substances on each and every lot of extract produced, thus asssuring their quality and therapeutic efficacy. Consumption of guarana by the population should be controlled, since there is controversy as to its dosage and association with allopathic drugs, the interactions of which may result in increasing the therapeutic effect, reducing efficacy or even bringing about adverse reactions. However, the use of guarana in adequate concentrations may contribute to achieve therapeutic properties with less toxicity on account of it being some natural antioxidants source and considered one of the most important new substances directly used as effective medicinal agents.

Keywords:
Paullinia cupana guaraná sapindaceae Amazônia

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Souza, V.C. and Lorenzi, H. Botânica Sistemática: guia ilustrado para identificação das famílias de angiospermas da flora brasileira, baseado em APG II, 2nd edition, New Odessa, Plantarum Institute, 2008.
[2]	Espínola, E.B., Dias, R.F., Mattei, R. and Carlini, E.A., “Pharmacological activity of Guaraná (Paullinia cupana Mart.) in laboratory animals”, J Ethnopharmacol, 55(3). 223-229. 1997.
[3]	Otobone, F.J., Sanches, A.C.C., Nagae, R., Martins, J.V.C., Obici, S., De Mello, J.C.P. and Audi, E.A., “Effect of crude extract and its semi purified constituents from guaraná seeds [Paullinia cupana var. sorbilis (Mart.) Ducke] on cognitive performance in Morris Water Maze in Rats”, Arch Biol Technol, 48(5). 723-728. 2005.
[4]	Henman, A.R., “Guaraná (Paullinia cupana var. Sorbilis): Ecological and social perspectives on an economic plant of the central amazon basin”, J Ethnopharmacol, 6(3). 311-338. 1982.
[5]	Yamaguti-Sasaki, E., Ito, L.A., Canteli, V.C., Ushirobira, T.M., Ueda-Nakamura, T., Dias Filho, B.P., Nakamura, C.V. and De Mello, J.C.P., “Capacidade antioxidante e prevenção in vitr da formação de placas dentárias por extratos e taninos condensados de Paullinia cupana”, Molecules, 12(8). 1950-1963. 2007.
[6]	Hanasaki, Y., Ogawa, S. and Fukui, S., “The correlation betweeen active oxygens scavenging and antioxidative effects of flavonoids”, Free Radical Bio Med, 16(6). 845-850. 1997.
[7]	Moraes, M.L., Micke, G.A., Fujiya, N.M. and Tavares, M.F.M., “Separação e análise de metilxantinas em extratos de guaraná e erva-mate por eletroforese capilar”, Rev Analytica, 5(5). 44-50. 2003.
[8]	Heard, C.M., Johnson, S., Moss, G. and Thomas, C.P., “In vitro transdermal delivery of caffeine, theobromine, theophylline and catechin from extract of guarana, Paullinia cupana”, International Journal of Pharmaceutics, 317(1). 26-31. 2006.
[9]	Ushirobira, T.M.A., Yamaguti, E., Uemura, L.M., Nakamura, C.V., Filho, B.P.D. and Mello, J.C.P., “Chemical and microbiological study of extract from seeds of guaraná (Paullinia cupana var. Sorbilis)”, Latin American Journal of Pharmacy, 26(1). 5-9. 2007.
[10]	Revilla, J. Apontamentos para a cosmética amazônica, 2nd edition, Manaus: SEBRAE/INPA, 2002.
[11]	Rates, S.M.K. Metilxantinas. In: Simões, C.M.O., Schenkel, E.P., Gosmann, G., Mello, J.C.P., Mentz, L.A. and Petrovick, P.R. Farmacognosia da planta ao medicamento, 5th edition, Porto Alegre: Editora da UFSC, 2004.
[12]	Basile, A., Ferrara, G., Del Pezzo, M., Mele, G., Sorbo, S., Bassi, P. and Montesano, D. “Antibacterial and antioxidant activities of ethanol extract from Paullinia cupana Mart”, J. Ethnopharmacol, 102(1). 32-36. 2005.
[13]	Heard, C.M., Johnson, S., Moss, G. and Thomas, C.P., “In vitro transdermal delivery of caffeine, theobromine, theophylline and catechin from extract of guarana, Paullinia cupana”, Int J Pharmac, 317(1). 26-31. 2006.
[14]	Majhenič, L., Škerget, M. and Željko, Z.K., “Antioxidant and antimicrobial activity of guarana seed extracts”, Food Chemistry, 104(3). 1258-1268. 2007.
[15]	Alonso, J. Tratado de fitofármacos y nutracéuticos, Corpus Editorial y Distribuidora. Argentina, 2007.
[16]	Campos, A.R., Barros, A.I.S., Santos, F.A. and Rao, V.S.N., “Guarana (Paulinnia cupana Mart.) offers protection against gastric lesions induced by ethanol and indomethacin in rats”, Phytotherapy Research, 17(10).1199-1202.2003.
[17]	Renner, B., Clarke, G., Grattan, T., Beisel, A., Mueller, C., Werner, U., Kobal, G. and Brune, K., “Caffeine accelerates absorption and enhances the analgesic effect of acetaminophen”, J Clin Pharmacol, 47(6). 715-726. 2007.
[18]	Otobone, F.J., Sanches, A.C.C., Nagae, R., Martins, J.V.C., Sela, V.R., De Mello, J.C.P. and Audi, E.A., “A Effect of lyophilized extracts from guaraná seeds [Paullinia cupana var. sorbilis (Mart.) Ducke] on behavioral profiles in rats. Phitoterapy Research, 21(6). 531-535.2007.
[19]	Roncon, C.M., De Almeida, C.B., Klein, T., Mello, J.C.P. and Audi, E.A. “Anxiolytic effects of a semipurified constituent of guaraná seeds on rats in the elevated T-maze test”, Planta Medica, 77(3). 236-241. 2011.
[20]	Rangel, M.P., De Mello, J.C.P. and Audi, E.A. “Evaluation of neurotransmitters involved in the anxiolytic and panicolytic effect of the aqueous fraction of Paullinia cupana (guaraná) in elevated T maze”, Revista Brasileira de Farmacognosia, 23(2). 358-365. 2013.
[21]	Fukumasu, H., Avanzo, J.L., Nagamine, M.K., Barbuto, J.Á., Rao, K.V. and Dagli, M.L.Z., “Paullinia cupana Mart. Var. Sorbilis, guarana, reduces cell proliferation and increases apoptosis of B16/F10 melanoma lung metastases in mice”, Brasilian Journal of Medical and Biological Reasearch, 41(4). 305-310. 2008.
[22]	Andersen, T. and Fogh, J., “Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients”, J Hum Nutr Dietet, 14(3). 243-250. 2001.
[23]	Lima, W.P., Carnevali, J.R.L.C., Eder, R., Rosa, L.F.B.P.C., Bacchi, E.M. and Seelaendera, M.C.L., “Lipid metabolismo in trained rats: Effect of guaraná (Paullinia cupana Mart.) supplementation”, Clinical Nutrition, 24(6).1019-1028.2005.
[24]	Ribeiro, J.A. and Sebastião, A.M., “Caffeine and adenosine”, J Alzh Dis, 20(Suppl 1). S3-S15.2010.
[25]	Dulloo, A.G., Geissler, C.A., Horton, T., Collins, A. and Miller, D.S., “Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers”, Am J Clin Nutr, 49(1). 44–50. 1989.
[26]	Boozer, C.N., Nasser, J.A., Heymsfield, S.B., Wang, V., Chen, G. and Solomon, J.L., “An herbal supplement containing Ma Huang-Guaraná for weight loss: a randomized, double-blind trial”, Int J Obes Relat Metab Disord, 25(3). 316-324. 2001.
[27]	Kennedy, D.O., Haskell, C.F., Robertson, B., Reay, J., Brewster-Maund, C., Luedemann J., Maggini, S., Ruf, M., Zangara, A., Scholey, A.B., “Improved cognitive performance and mental fatigue following a multi-vitamin and mineral supplement with added guaraná (Paullinia cupana)”, Appetite, 50(2-3). 506-513. 2008.
[28]	Campos, A.R., Barros, A.I.S., Albuquerque, F.A.A., Leal, L.K.A.M. and Rao, V.S.N., “Acute effects of Guarana (Paullinia cupana Mart.) on mouse behavior in forced swimming and open field tests”, Phytother Res, 19(5).441- 443. 2005.
[29]	Ray, S., Phadke, S., Patel, C., Hackman, R.M. and Stohs, S., “Short-term and long-term in vivo exposure to an ephedra- and caffeine-containing metabolic nutrition system does not induce cardiotoxicity in B6C3F1 mice”, Archives of Toxicology, 79(6).330-340.2005.
[30]	Tavares, C. and Sakata, R.K., “Caffeine in the Treatment of Pain”, Rev Bras Anestesiol, 62(3). 387-401. 2012.
[31]	Peroutka, S., Lyon, J.A., Swarbrick, J., Lipton, R.B., Kolodner, K. and Goldstein, J., “Efficacy of diclofenac sodium softgel 100 mg with or without caffeine 100 mg in migraine without aura: a randomized, double-blind, crossover study”, Headache, 44(2). 136-141. 2004.
[32]	Kuskoski, E.M., Roseane, F., García, A.A. and Troncoso, G.A.M., “Chemical and pharmacological properties of the fruit Guaraná (Paullinia cupana)”, Vitae, 12(2).45-52. 2005.
[33]	Mattei, R., Dias, R.F., Espínola, E.B., Carlini, E.A. and Barros, S.B.M., “Guarana (Paullinia cupana): toxic behavioral effects in laboratory animals and antioxidant activity in vitro”, J Ethnopharmacol, 60(2).111-116. 1998.
[34]	Yonekura, L., Martins, C.A., Sampaio, G.R., Monteiro, M.P., César, L.A.M., Mioto, B.M., Mori, C.S., Mendes, T.M.N., Ribeiro, M.L., Arçari, D.P. and Torres, E.A.F.S., “Bioavailability of catechins from guaraná (Paullinia cupana) and its effect on antioxidant enzymes and other oxidative stress markers in healthy human subjects”, Food & Function, 7(7). 2970-2978. 2016.
[35]	Fukumasu, H., Avanzo, J.L., Heidor, R., Silva, T.C., Atroch, A., Moreno, F.S. and Dagli, M.L., “Efeitos protetores do guaraná (Paullinia cupana Mart. Var. Sorbilis) contra o dano do DNA induzido por DEN no fígado do mouse”, Food Chem Toxicol, 44(6). 862-867. 2006.
[36]	Chung, K.T., Lu, Z. and Chou, M.W., “Mechanism of inhibition of tannic acid and related compounds on the growth of intestinal bacteria”, Food and Chemical Toxicology, 36(12). 1053-1060. 1998.
[37]	Vankemmelbeke, M.N., Jones, G.C., Fowles, C., Ilic, M.Z., Handley, C.J., Day, A.J., Knight, C.G. , Mort, J.S. and Buttle, D.J., “Selective inhibition of ADAMTS-1, -4 and -5 by catechin gallate esters”, Eur J Biochem, 270(11). 2394-2403. 2003.
[38]	Andriamanalijaona, R., Kypriotou, M., Bauge, C., Renard, E., Legendre, F., Raoudi, M., Boumediene, K., Gatto, H., Monginoux, P. and Pujol, J.P., “Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes”, J Rheumatol, 32(10). 1958-1967. 2005.
[39]	Singh, R., Ahmed, S., Malemud, C.J., Goldberg, V.M. and Haqqi, T.M., “Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes”, J Orthop Res, 21(1). 102-109. 2003.
[40]	Lin, S.K., Chang, H.H., Chen, Y.J., Wang, C.C., Galson, D.L., Hong, C.Y. and Kok, S.H., “Epigallocatechin-3-gallate diminishes CCI2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-Kinase/Akt/Raf-1 interaction: a potential therapeutic benefit for arthritis”, Arthritis Rheum, 58(10). 3145-3156. 2008.
[41]	Lee, J.H., Jin, H., Shim, H.E., Kim, H.N., Ha, H. and Lee, Z.H., “Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the NF-κB signal. Mol Pharmacol”, 77(1). 17-25.2010.
[42]	Morinobu, A., Biao, W., Tanaka, S., Horiuchi, M., Jun, L., Tsuji, G., Sakai, Y., Kurosaka, M. and Kumagai S., “(-)-Epigallocatechin-3-gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice”, Arthritis Rheum, 58(7). 2012-8. 2008.
[43]	Ottaviani, J. I., Momma, T. Y., Heiss, C., Kwik-Uribe, C., Schroeter, H. and Keen, C. L., “The stereochemical configuration of flavanols influences the level and metabolism of flavanols in humans and their biological activity in vivo”, Free Radical Biology and Medicine, 50.(2). 237-244. 2010.
[44]	Tfouni, S. A. V.; Camargo, M. C. R.; Vitorino, S. H. P.; Menegário, T. F. and Toledo, M. C. F., “Contribution of guaraná powder (Paullinia cupana) as a source of caffeine in the diet”, Revista de Nutrição, 20(1).63-68. 2007.
[45]	Bara, M.T.F., Ribeiro, P.A.M., Arantes, M.C.B., Amorim, L.L.S.S. and Paula, J.R., “Determinação do teor de princípios ativos em matérias-primas vegetais”, Rev Bras Farmacogn, 16(2). 211-215. 2006.
[46]	Pizza, C., Rastrelli, L., Totaro, K. and De Simone, F., Il Guaraná degli Indios Sateré-Maué. Istituto Italo-Latinoamericana, Rome: Serie Scienza. Paullinia cupana (guaraná) determinazione degli alcaloidi xantinici per la valutazione della qualitá di prodotti base di guaraná. 13-22. 1999.
[47]	Smith, N. and Atroch, A.L., “Guaraná's Journey from Regional Tonic to Aphrodisiac and Global Energy Drink”, Evid Based Complement Alternat Med, 7(3). 279-282. 2010.
[48]	Pittler, M.H., Schmidt, K. and Ernst, E., “Adverse events of herbal food supplements for body weight reduction: systematic review. The international Association for the Study of Obesity”, Obesity Reviews, 6(2). 93-111. 2005.
[49]	Sharpe, P.A., Granner, M.L., Conway, J.M., Ainsworth, B.E. and Dobre, M., “Availability of weight-loss supplements: results of na audito f retail outlets in a southeastern city”, Journal of the American Dietetic Association, 106(12). 2045-2051. 2006.
[50]	Babu, K.M., Church, R.J. and Lewander, W., “Energy Drinks: The New Eye-Opener For Adolescents”, Clin Ped Emerg Méd, 9(1). 35-42, 2008.
[51]	Kennedy, D.O., Haskell, C.F., Wesnes, K.A. and Scholey, A.B. “Improved cognitive performance in human volunteers following administration of guarana (Paullinia cupana) extract: comparison and interaction with Panax ginseng”, Pharmacology, Biochemistry and Bahavior, 79(3). 401-411. 2004.
[52]	Santa Maria, A., Lopez, A., Diaz, M.M., Munoz-Mingarro, D. and Pozuelo, J.M., “Evaluation of the toxicity of guaraná with in vitro bioassays”, Ecotoxicology and environmental safety, 39(3). 164-167. 1998.
[53]	Bittencourt, L.S., Machado, D.C., Machado, M.M., Dos Santos, G.F.F., Algarve, T.D., Marinowic, D.R., Ribeiro, E.E., Soares, F.A.A., Barbisan, F., Athaíde, M.L. and Cruz, I.B.M., “The protective effects of guaraná extract (Paullinia cupana) on fibroblast NIH-3T3 cells exposed to sodium nitroprusside”, Food and Chemical Toxicology, 53.119-125. 2013.
[54]	Salunkhe, D.K., Chavan, J.K. and Kadam, S.S. Dietary tannins: consequences and remedies, Boca Raton: CRC Press, 1990. 200p.
[55]	Sgarbieri, V.C. Proteínas em alimentos protéicos: propriedades - degradações - modificações. Cap. 5: Deterioração e modificações químicas, físicas e enzimáticas de proteínas. São Paulo: Varela; 1996.
[56]	Deshpande, S.S., Cheryan, M. and Salunkhe, D.K., “Tannin analysis of food products”, CRC Critical Reviews in Food Science and Nutrition, 24(4). 401-449. 1986.
[57]	Singleton, V.L., “Naturally occurring food toxicants: phenolic substances of plant origin common in food”, Advances in Food Research, 27.149-242. 1981.
[58]	Salunkhe, D.K., Jadhav, S.J., Kadam, S.S. and Chavan, J.K., “Chemical, biochemical, and biological significance of polyphenols in cereals and legumes”, CRC Critical Reviews in Food Science and Nutrition, 17(3). 277-305. 1982.
[59]	Bartolomé, B., Jiménez- Ramsey, L.M. and Butler, L.G., “Nature of the condensed tannins present in the dietary fibre fractions in foods”, Food Chemistry, 53(4). 357-362. 1995.
[60]	Rao, B.S.N. and Prabhavathi, T., “Tannin content of foods commonly consumed in India and its influence on ionisable iron”, Journal of the Science of Food Agriculture, 33(1). 89-96.1982.
[61]	Siegenberg, D., Baynes, R.D., Bothwell, T.H., Macfarlane, B.J., Lamparelli, R.D., Car, N.G., McPhail, P., Schmitd, U., Tal, A. and Mayet, F., “Ascorbic acid prevents the dose-dependent inhibitory effects of polyphenols and phytates on nonheme-iron absorption”, American Journal of Clinical Nutrition, 53. 537-541.1991.
[62]	Proulx, W.R., Weaver, C.M. and Bock, M.A. “Trypsin inhibitor activity and tannin content do not affect calcium bioavaliability of three commonly consumed legumes”, Journal of Food Science, 58(2). 382-384.1993.
[63]	Heaney, R.P., “Effects of caffeine on bone and calcium economy”, Food Chem. Toxicol, 40: 1263-1270.2002.
[64]	Nawrot, P., Jordan, S., Eastwood, J., Rotstein, J., Hugenholtz, A. and Feeley, M., “Effects of caffeine on human health”, Food Addit Contam, 20(1).1-30.2003.
[65]	De Maria, C.A.B. and Moreira, R.F.A., “Cafeína: revisão sobre métodos de análise”, Quim Nova, 30(1). 99-105. 2007.
[66]	Anvisa. Agência Nacional de Vigilância Sanitária. Instrução Normativa n. 05/2008. Dispõe sobre o Lista de Medicamentos Fitoterápicos de Registro Simplificado. Brasília (Brasil): Ministério da Saúde 2008. Available: http://189.28.128.100/dab/docs/legislacao/instrucao05_11_12_08.pdf. [Accessed April 02, 2018].
[67]	Ogava, S.E.M., Pinto, M.T.C., Kikuchi, T., Menegueti, V.A.F., Martins, D.B.C., Coelho, S.A.D., Marques, M.J.N.J.; Virmond, J.C.S.; Monteschio, P., D'Aquino, M. and Marques, L.C., “Implantação do programa de fototerapia “Verde Vida” na secretaria de saúde de Maringá (2000-2003)”, Revista Brasileira de Farmagnosia, 13(suppl.1). 58-62. 2003.
[68]	Nicoletti, M.A., Oliveira-Junior, M.A., Bertasso, C.C., Coporossi, T.Y. and Tavares, A.P.L., “Principais interações no uso de medicamentos fitoterápicos”, Infarma, 19(1/2). 32-40. 2007.
[69]	Gonçalves, N.M.T., Gerenutti, M., Chaves, D.S.A., Vila and M.M.D.C., “The folk tradition as a tool for the deployment of phytotherapy in the city of Volta Redonda – RJ”, Rev. Bras. Farm. 92(4). 346-351. 2011.
[70]	Freitas, R.S., Moreno, S.R.F., Lima-Filho, G.L., Fonseca, A.S. and Bernardo-Filho, M., “Effect of a commercial extract of Paullinia cupana (guarana) on the binding of 99mTc-DMSA on blood constituents: An in vivo study”, Applied Radiation and Isotopes, 65(5). 528-533. 2007.
[71]	Kuri, C.M.B., “The guarana industry in Brazil”, International Business and Economics Research Journal, 7. 87-98. 2008.
[72]	Futuro, D.O., Fiorini, F.S. and Castilho, S.R., “Interações entre Plantas e Medicamentos”, Informativo CEATRIM, 2004. Available: http://www.crf-rj.org.br/crf/infor/cetrim/arquivos/200412_CEATRIM.pdf. [Accessed April 10, 2018].
[73]	Izzo, A.A. and Ernst, E., “Interactions between herbal medicines and prescribed drugs: A systematic review”, Drugs, 61(15).2163-2175.2001.
[74]	Veiga Junior, V.F., Pinto, A.C. and Maciel, M.A.M., “Plantas medicinais: cura segura?”, Química Nova. 28(3).519-528.2005.
[75]	Anvisa. Agência Nacional de Vigilância Sanitária. Farmacopéia Brasileira. 5. ed. Brasília: Ministério da Saúde, 1.524.2010. Available: http://www.anvisa.gov.br/hotsite/cd_farmacopeia/pdf/volume1.pdf. [Accessed May 25, 2018].
[76]	Brito, R.S. “O guaraná”, Agric e Pec, 2(42). 619-21.1930.
[77]	Barretto, L.P., “O Guaraná: a planta e suas virtudes, utilização e exportação”, O Campo, 103.45-50. 1938.
[78]	Watzel, J., “O guaraná, seu valor industrial e medicinal”, Boletim do Ministério de Agricultura, 26(416). 25-32. 1937.
[79]	Machado, O., “Contribuição ao estudo das plantas medicinais do Brasil: O Guaraná”, Rodriguesia. 20(9). 89-110. 1946.
[80]	Castro, J.B. de A.A., “A cultura do guaraná na Bahia”, Suplemento Agrícola de O Estado de São Paulo, 20(999). 8-10. 1974.
[81]	Carlini, E. A., “Plants and the central nervous system”, Pharmacology, Biochemistry and Behavior, 75(3).501-512.2003.
[82]	Sporn, M.B. and Suh, N., “Chemoprevention: uma abordagem essencial para controlar o câncer”, Nat Rev Cancer, 2(7). 537-543. 2002.
[83]	Yang, H., Rouse, J., Lukes, L., Lancaster, M., Veenstra, T., Zhou, M., Shi, Y., Yeong-Gwan, P., Hunter, K., “Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis”, Clin Exp Metastasis, 21(8). 719-735. 2005.
[84]	Firmo, W.C.A., Menezes, V.J.M., Passos, C.E.C., Dias, C.N., Alves, L.P.L., Dias, I.C.L., Neto, M.S. and Olea, R.S.G., “Historical context, popular use and scientific conception on medicinal plants”, Cad Pesq, 18. 90-94. 2011.
[85]	Klein, T., Longhini, R., Bruschi, M.L. and Mello, J.C.P., “Fitoterápicos: um mercado promissor”, J Basic Appl Pharm Sci, 30. 241-248. 2009.
[86]	Andrade, L., Schenkel, E.P. and Bergold, A.M., “Estudo da metodologia de análise de cafeína em sementes de guaraná (Paullinia cupana)”, Rev Bras Farm, 80. 7-9. 1999.
[87]	Simões, C.L.O., Schenkel, E.P., Gosmann, G., Mello J.C.P., Mentz, L.A. and Petrovick, P.R., Farmacognosia: da Planta ao Medicamento, 5. ed. Porto Alegre, Editora UFRGS; Florianópolis: UFSC, 821. 2003.
[88]	Santos, S.C. and Mello, J.C.P., Taninos. In: Simões CMO (org.). Farmacognosia da planta ao medicamento. 5. ed. Porto Alegre: Editora da Universidade Federal do Rio Grande do Sul, 615-656. 2007.
[89]	Subbiah, M.T. and Yunker, R., “Studies on the nature of anti-platelet aggregatory factors in the seeds of the Amazonian Herb Guarana (Paullinia cupana)”, International Journal for Vitamin and Nutrition Research, 78. 96-101, 2008.
[90]	Gnoatto, S.C.B., Bassani, V.L., Coelho, G.C. and Schenkel, E.P., “Influência do método de extração nos teores de metilxantinas em erva-mate (Ilex paraguariensis a. st.-hil., aquifoliaceae)”, Química nova, 30(2). 304-307. 2007.